You are here

melanoma

Initial Ph II 2b Results of Elios' Personalized Cancer Vaccine for the Treatment of Melanoma Look Promising

Initial Ph II 2b Results of Elios' Personalized Cancer Vaccine for the Treatment of Melanoma Look Promising

CP Wire

Elios Therapeutics

clinical trials

Flag link:

Keytruda Adjuvant Therapy Study Shows Reduced the Risk of Disease Recurrence or Death by More Than 40 Percent Compared to Placebo in Stage III Melanoma

Keytruda Adjuvant Therapy Study Shows Reduced the Risk of Disease Recurrence or Death by More Than 40 Percent Compared to Placebo in Stage III Melanoma

CP Wire

anti-PD-1 immunotherapy

Flag link:

Keytruda Adjuvant Therapy Study Shows Reduced the Risk of Disease Recurrence or Death by More Than 40 Percent Compared to Placebo in Stage III Melanoma

Flag link:

Wistar Researchers Find Combination Therapy Effective for NRAS Mutant and Therapy Resistant Melanoma

Wistar Researchers Find Combination Therapy Effective for NRAS Mutant and Therapy Resistant Melanoma

CP Wire

Wistar Institute

Flag link:

Wistar Researchers Find Combination Therapy Effective for NRAS Mutant and Therapy Resistant Melanoma

Flag link:

Incyte's stock plunges, Merck shares fall after disappointing study results of melanoma treatment

Incyte's stock plunges, Merck shares fall after disappointing study results of melanoma treatment

Marketwatch

clinical trials

metastatic melanoma

Flag link:

FDA approves new dosing for Bristol-Myers Squibb's Opdivo

FDA approves new dosing for Bristol-Myers Squibb's Opdivo

Yahoo/Reuters

Bristol-Myers Squibb

Flag link:

Merck’s melanoma drug shows early promise for resistant cancers in PhI trial

Merck’s melanoma drug shows early promise for resistant cancers in PhI trial

Endpoints

clinical trials

Flag link:

Array melanoma drugs show significant survival versus Roche drug in study

Array melanoma drugs show significant survival versus Roche drug in study

Reuters

Array Biopharma

Flag link:

Merck's Keytruda nabs new data to rival Bristol-Myers' Opdivo at fending off melanoma's return

Merck's Keytruda nabs new data to rival Bristol-Myers' Opdivo at fending off melanoma's return

Fierce Pharma

Bristol-Myers Squibb

Flag link:

OncoSec shares turn hot as microcap reports promising PhII data for an I/O one-two punch

OncoSec shares turn hot as microcap reports promising PhII data for an I/O one-two punch

Endpoints

clinical trials

ImmunoPulse IL-12

Flag link:

Greek health minister takes issue with Roche’s withdrawal of cancer medicine due to mandatory discount

Greek health minister takes issue with Roche’s withdrawal of cancer medicine due to mandatory discount

Endpoints

Flag link:

OncoSec Seeks Accelerated Approval to Treat Melanoma

OncoSec Seeks Accelerated Approval to Treat Melanoma

Yahoo/GuruFocus

ImmunoPulse(R) IL-12

Flag link:

With Yervoy-beating data, Opdivo poised to fight melanoma's return after surgery

With Yervoy-beating data, Opdivo poised to fight melanoma's return after surgery

Fierce Pharma

Bristol-Myers Squibb

Flag link:

Selecting Anti-Melanoma Drug Targets

Selecting Anti-Melanoma Drug Targets

Elsevier

Flag link:

Exelixis and Genentech hammer out new deal terms

Exelixis and Genentech hammer out new deal terms

BioPharma Dive

Flag link:

Bristol Myers Vies to Be King of Immuno-Boosting Cancer Drugs with New Trial Update

Bristol Myers Vies to Be King of Immuno-Boosting Cancer Drugs with New Trial Update

TheStreet.com

Bristol-Myers Squibb

Flag link:

Personalized cancer vaccines vanquish melanoma in small but encouraging study

Personalized cancer vaccines vanquish melanoma in small but encouraging study

Stat

personalized medicine

Neon Therapeutics

Flag link:

Bristol-Myers’ tarnished checkpoint star Opdivo beats out Yervoy in surprise PhIII

Bristol-Myers’ tarnished checkpoint star Opdivo beats out Yervoy in surprise PhIII

Endpoints

Bristol-Myers Squibb

Flag link:

Checkmate Pharma Clinches $27M for More Studies in Skin Cancer

Checkmate Pharma Clinches $27M for More Studies in Skin Cancer

Xconomy

Checkmate Pharmaceuticals

Flag link:

Pages